Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition

Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition

Abstract Background Parkinson’s disease (PD) is a neurodegenerative condition that is characterized by a progressive decline of neural pathways, and its pathology is associated with alpha-synuclein abnormalities. Currently, infertility affects about 10% of individuals of fertile age within the USA....

Full description

Bibliographic Details
Main Authors:	Velu Krishnan, Shivani S. Patel, Priyanka Shenoy, Jessica Cottrell
Format:	Article
Language:	English
Published:	SpringerOpen 2023-09-01
Series:	Middle East Fertility Society Journal
Subjects:	Ingenuity Pathway Analysis (IPA) Parkinson’s disease (PD) Infertility condition (IC) Nicotine Alpha-synuclein (SNCA)
Online Access:	https://doi.org/10.1186/s43043-023-00148-4

Similar Items

Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
by: Alix Booms, et al.
Published: (2021-10-01)

Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation
by: Katharina Pieger, et al.
Published: (2022-08-01)

Genetic Elements at the Alpha-Synuclein Locus
by: Jordan Prahl, et al.
Published: (2022-07-01)

Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes
by: Yihang Han, et al.
Published: (2022-06-01)

Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression
by: Sara J. Fagen, et al.
Published: (2023-08-01)

Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson’s Patient-Derived Neuronal Cells
by: Lukas Seebauer, et al.
Published: (2022-02-01)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
by: Angeliki Spathopoulou, et al.
Published: (2022-01-01)

Subthalamic deep brain stimulation in Parkinson's disease with SNCA mutations: Based on the follow‐up to 10 years
by: Jinyoung Youn, et al.
Published: (2022-02-01)

Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease
by: Desiree A. Piper, et al.
Published: (2018-04-01)

Alpha-synuclein dynamics bridge Type-I Interferon response and SARS-CoV-2 replication in peripheral cells
by: Fiona Limanaqi, et al.
Published: (2024-01-01)

DNA methylation in Parkinson disease
by: Elena V. Yakovenko, et al.
Published: (2020-12-01)

The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders
by: C. Alejandra Morato Torres, et al.
Published: (2020-08-01)

In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies
by: Mohamed E. Elnageeb, et al.
Published: (2023-09-01)

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease
by: Laura Marsal-García, et al.
Published: (2021-01-01)

Alpha-synuclein as a biomarker of Parkinson’s disease
by: S. N. Pchelina
Published: (2017-02-01)

Transcriptome Analysis in a Mouse Model of Premature Aging of Dentate Gyrus: Rescue of Alpha-Synuclein Deficit by Virus-Driven Expression or by Running Restores the Defective Neurogenesis
by: Laura Micheli, et al.
Published: (2021-08-01)

Autoclave treatment fails to completely inactivate DLB alpha-synuclein seeding activity
by: Jung-Youn Han, et al.
Published: (2023-07-01)

Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson’s Model
by: Jessica IChi Lai, et al.
Published: (2023-02-01)

Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC
by: Jung-Youn Han, et al.
Published: (2021-04-01)

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
by: Marco J. Russo, et al.
Published: (2021-11-01)

Alpha-Synuclein Aggregation in Parkinson's Disease
by: E. Srinivasan, et al.
Published: (2021-10-01)

Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy
by: Ivan Martinez-Valbuena, et al.
Published: (2022-02-01)

Variants in SNCA Gene Are Associated with Parkinson’s Disease Risk and Cognitive Symptoms in a Brazilian Sample
by: Clarissa L.C Campêlo, et al.
Published: (2017-06-01)

Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson’s Disease
by: Dominika Fricova, et al.
Published: (2020-11-01)

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
by: Couch Yvonne, et al.
Published: (2011-11-01)

A population scale analysis of rare SNCA variation in the UK Biobank
by: Cornelis Blauwendraat, et al.
Published: (2021-01-01)

Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol
by: Sarah Threlfell, et al.
Published: (2021-04-01)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
by: Rachel Kelly, et al.
Published: (2021-11-01)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
by: Puyu Li, et al.
Published: (2021-10-01)

Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study
by: Kari Anne Bjørnarå, et al.
Published: (2018-02-01)

Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
by: Demetrius M. Maraganore
Published: (2011-05-01)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
by: Shengli Xu, et al.
Published: (2015-06-01)

Parkinson Hastalığı ve İlişkili Olduğu Genler
by: Yener Kurman
Published: (2018-01-01)

SNCA rs3910105 Is Associated With Development of Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s Disease
by: Nan-nan Yang, et al.
Published: (2022-03-01)

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s Disease
by: Meng Cai, et al.
Published: (2021-08-01)

SUMOylation of Alpha-Synuclein Influences on Alpha-Synuclein Aggregation Induced by Methamphetamine
by: Lin-nan Zhu, et al.
Published: (2018-08-01)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
by: Guoxin Zhang, et al.
Published: (2018-11-01)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
by: Carroll Rutherford Fields, et al.
Published: (2019-12-01)

Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson’s Disease Progression in Mice
by: Seon-Young Park, et al.
Published: (2023-10-01)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
by: Maria Angela Samis Zella, et al.
Published: (2019-01-01)